We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
-3.14%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$52.8B
AUM Growth
-$1.34B
(-2.5%)
Cap. Flow
+$1.39B
Cap. Flow
% of AUM
2.62%
Top 10 Holdings %
Top 10 Hldgs %
12%
Holding
4,607
New
780
Increased
956
Reduced
789
Closed
1,336
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$532M |
| 2 |
Wells Fargo
WFC
|
+$480M |
| 3 |
Visa
V
|
+$435M |
| 4 |
Verizon
VZ
|
+$320M |
| 5 |
Broadcom
AVGO
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$547M |
| 2 |
Meta Platforms (Facebook)
META
|
+$525M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$498M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$456M |
| 5 |
Amazon
AMZN
|
+$445M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.66% |
| 2 | Technology | 16.35% |
| 3 | Healthcare | 16.13% |
| 4 | Consumer Discretionary | 11.2% |
| 5 | Industrials | 7.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3101
Everspin Technologies
MRAM
$328M
| $179K | ﹤0.01% |
20,478
-7,835
| -28% | -$75K |
|
|
ADN
3102
DELISTED
Advent Technologies
ADN
| $178K | ﹤0.01% |
+2,547
| New | +$288K |
|
|
CIFRW
3103
CALL
DELISTED
Cipher Mining Warrant
CIFRW
| $176K | ﹤0.01% |
48,720
| – | – |
|
|
DAWN
3104
DELISTED
Day One Biopharmaceuticals
DAWN
| $176K | ﹤0.01% |
+17,743
| New | +$234K |
|
3105
Huntington Bancshares
HBAN
$35B
| $176K | ﹤0.01% |
+12,009
| New | +$188K |
|
|
AOGO
3106
DELISTED
Arogo Capital Acquisition Corp. Class A Common Stock
AOGO
| $176K | ﹤0.01% |
+17,678
| New | +$175K |
|
3107
PUT
Citigroup
C
$222B
| $171K | ﹤0.01% |
+3,200
| New | +$198K |
|
|
NETI
3108
DELISTED
Eneti Inc.
NETI
| $169K | ﹤0.01% |
26,717
+23,923
| +856% | +$162K |
|
|
ITI
3109
DELISTED
Iteris, Inc.
ITI
| $168K | ﹤0.01% |
56,569
-17,585
| -24% | -$60.9K |
|
3110
Arteris
AIP
$1.34B
| $167K | ﹤0.01% |
12,854
-25,573
| -67% | -$382K |
|
3111
BTCS Inc
BTCS
$51.8M
| $167K | ﹤0.01% |
40,095
+9,665
| +32% | +$44.1K |
|
|
MTA
3112
Metalla Royalty & Streaming
MTA
$688M
| $167K | ﹤0.01% |
23,538
-139,651
| -86% | -$975K |
|
3113
Goldgroup Mining Inc.
GORO
$152M
| $163K | ﹤0.01% |
72,638
-266,189
| -79% | -$493K |
|
|
MTAL
3114
DELISTED
Metals Acquisition
MTAL
| $162K | ﹤0.01% |
16,323
| – | – |
|
3115
Daktronics
DAKT
$953M
| $156K | ﹤0.01% |
40,583
-55,014
| -58% | -$253K |
|
3116
Alzamend Neuro
ALZN
$4.98M
| $154K | ﹤0.01% |
92
-29
| -24% | -$54.5K |
|
3117
CareCloud
CCLD
$100M
| $154K | ﹤0.01% |
29,828
-19,759
| -40% | -$108K |
|
3118
InfuSystem Holdings
INFU
$200M
| $154K | ﹤0.01% |
+15,638
| New | +$201K |
|
3119
Melco Resorts & Entertainment
MLCO
$2.19B
| $154K | ﹤0.01% |
20,140
-54,198
| -73% | -$521K |
|
|
BVC
3120
BitVentures Limited Ordinary Shares
BVC
$1.79B
| $149K | ﹤0.01% |
+20,020
| New | +$124K |
|
|
MKFG
3121
DELISTED
Markforged Holding Corporation
MKFG
| $148K | ﹤0.01% |
3,713
-23,324
| -86% | -$1.02M |
|
3122
Bioventus
BVS
$895M
| $147K | ﹤0.01% |
10,440
-164,751
| -94% | -$2.21M |
|
3123
Acacia Research
ACTG
$447M
| $146K | ﹤0.01% |
32,317
+12,990
| +67% | +$54.6K |
|
3124
LSI Industries
LYTS
$880M
| $146K | ﹤0.01% |
24,400
+2,742
| +13% | +$18.2K |
|
3125
Splash Beverage Group
SBEV
$2.22M
| $144K | ﹤0.01% |
+319
| New | +$163K |
|
Similar funds
Marshall Wace's Q1 2022 Portfolio in Review
As of Q1 2022, Marshall Wace held 4,607 positions worth $52.8B, down 2.5% from $54.2B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Marshall Wace's Q1 2022 filing shows 780 new, 956 increased, 789 reduced and 1,336 closed positions. Its largest new stake was Agilent Technologies: 1,082,487 shares worth $143M. The largest sale was Microsoft, an estimated $547M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.
- Marshall Wace's largest Q1 2022 buy was Agilent Technologies: 1,082,487 shares worth $143M.
- Marshall Wace added most to Merck in Q1 2022, an estimated $532M increase.
- Marshall Wace's biggest Q1 2022 reduction was Microsoft, cutting an estimated $547M.
- Marshall Wace fully exited Elevance Health in Q1 2022, selling an estimated $226M.
- Marshall Wace's ten largest holdings make up 12% of its $52.8B portfolio in Q1 2022.
- Marshall Wace opened 780 new positions and closed 1,336 in Q1 2022.
- Marshall Wace's portfolio value fell 2.5% quarter-over-quarter to $52.8B.
Based on Marshall Wace's 13F filing for Q1 2022, filed 16 May 2022.